Loss of Heterozygosity on Chromosome 9q22.3 in Microdissected Basal Cell Carcinomas Around the Semipalatinsk Nuclear Testing Site, Kazakhstan

Human Pathology

Volumn 35, Issue 4, 2004, Pages 460-464

  Iwata, Kenji ^b   Takamura, Noboru ^a   Nakashima, Masahiro ^b   Alipov, Gabit ^b   Mine, Mariko ^b   Matsumoto, Naomichi ^b   Yoshiura, Koichiro ^b   Prouglo, Yuriy ^b   Sekine, Ichiro ^b   Katayama, Ichiro ^b   Yamashita, Shunichi ^b  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^b NONE

Author keywords

9q22.3; Basal cell carcinoma; Loss of heterozygosity; Semipalatinsk Nuclear Testing Site

Indexed keywords

ADULT; AGED; ARTICLE; ATOMIC BOMB; BASAL CELL CARCINOMA; CANCER INCIDENCE; CHROMOSOME 9Q; CHROMOSOME MICRODISSECTION; CLINICAL ARTICLE; CONTROLLED STUDY; FALLOUT; FEMALE; GENE; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; KAZAKHSTAN; MALE; MOLECULAR CLONING; POLYMERASE CHAIN REACTION; PTCH GENE; STATISTICAL ANALYSIS; XPA GENE;

EID: 11144353901     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2003.09.021     Document Type: Article

References (28)

1. Yamamoto M, Tsukatani T, Katayama Y: Residual radioactivity in the soil of the Semipalatinsk nuclear test site in the former USSR. Health Phys 71:142-148, 1996
2. Gusev BI, Abylkassimova ZN, Apsalikov KN: The Semipalatinsk nuclear test site: A first assessment of the radiological situation and the test-related radiation doses in the surrounding territories. Radiat Environ Biophys 36:201-204, 1997
3. Grimwood RE, Siegle RJ, Ferris CF, et al: The biology of basal cell carcinomas: A revisit and recent developments. J Dermatol Surg Oncol 12:805-808, 1986
4. Preston DS, Stern RS: Nonmelanoma cancers of the skin. N Engl J Med 357:1649-1662, 1992
5. Stante M, Salvini C, De Giorgi V, et al: Multiple synchronous pigmented basal cell carcinomas following radiotherapy for Hodgkin's disease. Int J Dermatol 41:208-211, 2002
6. Martin H, Strong E, Spiro R: Radiation-induced skin cancer of the head and neck. Cancer 25:61-71, 1970
7. Karagas MR, McDonald JA, Greenberg ER, et al, for the Skin Cancer Prevention Study Group: Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy. J Natl Cancer Inst 88:1848-1853, 1996
8. O'Malley S, Weitman D, Olding M, et al: Multiple neoplasms following craniospinal irradiation for medulloblastoma in a patient with nevoid basal cell carcinoma syndrome: Case report. J Neurosurg 86:286-288, 1997
9. Gailani MR, Leffell DJ, Ziegler A, et al: Relationship between sunlight exposure and a key genetic alteration in basal cell carcinoma. J Natl Cancer Inst 88:349-354, 1996
10. Rady P, Scinicariello F, Wagner RF Jr, et al: p53 mutations in basal cell carcinomas. Cancer Res 52:3804-3806, 1992
11. Hahn H, Wicking C, Zaphiropoulous PG, et al: Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma. Cell 85:841-851, 1996
12. Johnson RL, Rothman AL, Xie J: Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science 272:1668-1671, 1996
13. Stone DM, Hynes M, Armanini M: The tumour-suppressor gene patched encodes a candidate receptor for Sonic hedgehog. Nature 384:129-134, 1996
14. Wicking C, Shanley S, Smyth I, et al: Most germ-line mutations in the nevoid basal cell carcinoma syndrome lead to a premature termination of the PATCHED protein, and no genotype-phenotype correlations are evident. Am J Hum Genet 60:21-26, 1997
15. Evans T, Boonchai W, Shanley S, et al: The spectrum of patched mutations in a collection of Australian basal cell carcinomas. Hum Mutat 16:43-48, 2000
16. Xin H, Matt D, Qin JZ, et al: The sebaceous nevus: A nevus with deletions of the PTCH gene. Cancer Res 59:1834-1836, 1996
17. Shen T, Park WS, Boni R, et al: Detection of loss of heterozygosity on chromosome 9q22.3 in microdissected sporadic basal cell carcinoma. HUM PATHOL 30:284-287, 1990
18. Cleaver JE, Thompson LH, Richardson AS, et al: A summary of mutations in the UV-sensitive disorders: Xeroderma pigmentosum, Cockayne syndrome, and trichothiodystrophy. Hum Mutat 14:9-22, 1999
19. Li L, Elledge SJ, Peterson CA, et al: Specific association between the human DNA repair proteins XPA and ERCC1. Proc Natl Acad Sci U S A 91:5012-5016, 1994
20. Radford DM, Fair K, Thompson AM, et al: Allelic loss on a chromosome 17 in ductal carcinoma in situ of the breast. Cancer Res 53:2947-2949, 1993
21. Zhuang Z, Bertheau P, Emmert-Buck MR, et al: A microdissection technique for archival DNA analysis of specific cell populations in lesions <1 mm in size. Am J Pathol 146:620-625, 1995
22. Raha S, Merante F, Proteau G, et al: Simultaneous isolation of total cellular RNA and DNA from tissue culture cells using phenol and lithium chloride. Genet Anal Tech 7:173-177, 1990
23. Yamada M, Kodama K, Fujita S, et al: Prevalence of skin neoplasms among the atomic bomb survivors. Radiat Res 146:223-226, 1996
24. Ron E, Preston DL, Kishikawa M, et al: Skin tumor risk among atomic-bomb survivors in Japan. Cancer Causes Control 9:393-401, 1998
25. D'Errico M, Calcagnile A, Canzona F, et al: UV mutation signature in tumor-suppressor genes involved in skin carcinogenesis in xeroderma pigmentosum patients. Oncogene 19:463-467, 2000
26. Satokata I, Tanaka K, Miura N, et al: Characterization of a splicing mutation in group A xeroderma pigmentosum. Proc Natl Acad Sci U S A 87:9908-9912, 1990
27. Cleaver JE, Charles WC, Thomas GH, et al: A deletion and an insertion in the alleles for the xeroderma pigmentosum (XPA) DNA-biding protein in mildly affected patients. Hum Mol Genet 4:1685-1687, 1995
28. Kim MY, Park HJ, Baek SC, et al: Mutation of the p53 and PTCH gene in basal cell carcinomas: UV mutation signature and strand bias. J Dermatol Sci 29:1-9, 2002